PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
July 17, 2014 | ISSUE NUMBER 360 VOL 4

Vaccines
The Vaccines Market: Key Growth Factors
There is significant untapped potential in the preventive vaccines market, write IMS Consulting' s Kevin Fitzpatrick and Nitin Mohan. Among the factors driving growth are an increase in awareness of infectious diseases, changes in the global reimbursement landscape, and higher prices for new vaccines ...Read more

Vaccines
Takeda's New Vaccine Division Charts Course to Global Growth
Today's vaccines business represents an almost perfect world for Big Pharma. While the established players strive to keep their lead, and others contemplate entering the space for the first time, one company—Takeda Pharmaceuticals—is moving to up its game, with a commitment to build a truly global vaccines business ...Read more

The lifecycle of a new product is shorter, more contested, full of regulatory delays, and beset by a challenging access and reimbursement environment.  Learn how to wrest maximum value from every stage of the lifecycle – from access to acquisition to adherence – by downloading this eBook.

Forecast
Pharma A “Trillion Dollar Industry” by 2020
The new edition of EvaluatePharma's World Preview reports that worldwide prescription drug sales forecast will exceed the one trillion dollar mark by 2020. The prediction is based on the growing compound annual growth rate (CAGR) that the pharmaceutical industry is currently enjoying ...Read more

Biosimilars: Friend or Foe to Healthcare?
On Demand webcast
To Register atwww.pharmexec.com/biosimilars

Event
BIO 2014: The Surprising Take Away
A surprising take away from the BIO International Convention in San Diego last month is the stark contrast between cooperative industry engagement and an unstable geopolitical order marked by xenophobia, drift and active, often violent government disengagement from the hard work of building common ground. Pharm Exec's Editor-in-Chief William Looney reports ...Read more

Medical Technology
Fixing the MedTech Disconnect
The medical technology industry has a legacy of creating life-enhancing, life-extending products while rewarding investors in the process. This connection between innovation and profitability has been a fundamental driver for many companies. But, writes Doug Mown, this is about to change
...Read more

//CutisPharma (Wilmington, MA) appointed Neal Muni, MD, MSPH as President and member of the Board of Directors.//Illumina Inc. (San Diego, CA) named Tina S. Nova, Ph.D. as Senior Vice President and General Manager of its oncology business.//CADIA Pharmaceuticals Inc. (San Diego, CA) announced the appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer.//FORUM Pharmaceuticals Inc. (Watertown, MA, previously known as EnVivo Pharmaceuticals, Inc.) announced the appointment of Christine Boisclair as Vice President, Regulatory Affairs.//

August 12–13: Reimbursement and Access
Philadelphia, PA.


August 18–20: Transparency and Aggregate Spend
Washington, DC.

October 21–22: International Pharmaceutical Compliance Congress
Brussels, Belgium.



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin

 
 

Survey
What is pharma’s most pressing digital challenge?

Click To Vote
 

Quick Links

The Technologies Set to Transform Healthcare

Value-Based Assessment in the UK: Patient View

Industry Seeks Clearer Track and Trace Standards

Pharm Exec eBooks Available as Apps